Drug Indications Database™

Provides an Essential Component of Advanced Clinical Information Systems

HELPS  PREVENT INAPPROPRIATE PRESCRIBING
Drug Indications Database™ assists in identifying the drugs available to treat a specific medical condition. In doing so, it also facilitates adherence to federal drug use standards, identifies potential off-label drug uses and drug contraindications associated with inappropriately prescribed medications.

FEATURES

• Drug acceptance level - differentiates between FDA-approved indications, officially recognized unlabeled uses and other known unlabeled uses
• Role of therapy - distinguishes between short-term use and maintenance drugs
• Outcome - specifies the “expected” clinical result subsequent to drug use
• Treatment rank - identifies a specific drug's rank in managing a particular medical condition, (e.g., first-line, alternate)

• Microorganism code - identifies the microorganism that causes the medical condition
• Restricted medical condition - specifies drug indications limited to patients with a unique medical condition
• Co-treatment set - identifies drugs that must be used in combination
• Proxy - indicates the likelihood that a patient is taking a drug to manage a particular indication

BENEFITS

FOR HEALTH CARE FACILITIES

• Allows health care providers to differentiate between labeled and common off-label drug uses
• Assesses appropriate drug selection
• Helps reduce or eliminate hospitalizations, physician office visits, drug therapy, lab tests and other costs associated with inappropriate drug selection
• Optimizes therapeutic outcomes by identifying drugs that must be used in combination with other drugs to manage a condition
• Supports “proxy” medical condition identification, enabling users to infer medical conditions based on drug therapy when other information is unavailable
• Click here to download the PDF

FOR HEALTH CARE PROVIDERS

• Allowshealth care providers to differentiate between labeled and common off-label drug uses
• Assesses appropriate drug selection
• Helps reduce or eliminate hospitalizations, physician office visits, drug therapy, lab tests and other costs associated with inappropriate drug selection
• Optimizes therapeutic outcomes by identifying drugs that must be used in combination with other drugs to manage a condition
• Supports “proxy” medical condition identification, enabling users to infer medical conditions based on drug therapy when other information is unavailable
• Click here to download the PDF

FOR PAYERS

• Allows payers to differentiate between labeled and common off-label drug uses
• Provides OBRA '87 drug selection confirmation
• Assesses appropriate drug selection
• Helps reduce or eliminate hospitalizations, physician office visits, drug therapy, lab tests and other costs associated with inappropriate drug selection
• Optimizes therapeutic outcomes by identifying drugs that must be used in combination with other drugs to manage a condition
• Supports “proxy” medical condition identification, enabling users to infer medical conditions based on drug therapy when other information is unavailable
• Click here to download the PDF

FOR PHARMACISTS

• Allows pharmacists to differentiate between labeled and common off-label drug uses
• Provides long-term care pharmacists with OBRA '87 drug selection confirmation
• Assesses appropriate drug selection
• Helps reduce or eliminate hospitalizations, physician office visits, drug therapy, lab tests and other costs associated with inappropriate drug selection
• Optimizes therapeutic outcomes by identifying drugs that must be used in combination with other drugs to manage a condition
• Supports “proxy” medical condition identification, enabling users to infer medical conditions based on drug therapy when other information is unavailable
• Click here to download the PDF